SRT4 Stock Overview
Provides bioprocess solutions and lab products and services in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Sartorius Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €39.00 |
| 52 Week High | €55.00 |
| 52 Week Low | €32.00 |
| Beta | 1.04 |
| 1 Month Change | 2.09% |
| 3 Month Change | 21.88% |
| 1 Year Change | -26.42% |
| 3 Year Change | -40.00% |
| 5 Year Change | n/a |
| Change since IPO | -38.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| SRT4 | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -1.5% | -2.1% | -0.6% |
| 1Y | -26.4% | -6.9% | 14.8% |
Return vs Industry: SRT4 underperformed the German Life Sciences industry which returned -6.9% over the past year.
Return vs Market: SRT4 underperformed the German Market which returned 14.8% over the past year.
Price Volatility
| SRT4 volatility | |
|---|---|
| SRT4 Average Weekly Movement | 6.4% |
| Life Sciences Industry Average Movement | 6.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: SRT4 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: SRT4's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1870 | 13,177 | Joachim Kreuzburg | www.sartorius.com |
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products.
Sartorius Aktiengesellschaft Fundamentals Summary
| SRT4 fundamental statistics | |
|---|---|
| Market cap | €15.02b |
| Earnings (TTM) | €84.00m |
| Revenue (TTM) | €3.38b |
198.9x
P/E Ratio4.9x
P/S RatioIs SRT4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SRT4 income statement (TTM) | |
|---|---|
| Revenue | €3.38b |
| Cost of Revenue | €1.86b |
| Gross Profit | €1.52b |
| Other Expenses | €1.44b |
| Earnings | €84.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 16, 2025
| Earnings per share (EPS) | 1.22 |
| Gross Margin | 45.09% |
| Net Profit Margin | 2.48% |
| Debt/Equity Ratio | 112.3% |
How did SRT4 perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield61%
Payout RatioDoes SRT4 pay a reliable dividends?
See SRT4 dividend history and benchmarks| Sartorius dividend dates | |
|---|---|
| Ex Dividend Date | Mar 31 2025 |
| Dividend Pay Date | Apr 15 2025 |
| Days until Ex dividend | 37 days |
| Days until Dividend pay date | 52 days |
Does SRT4 pay a reliable dividends?
See SRT4 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/22 08:37 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sartorius Aktiengesellschaft is covered by 42 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Theresa Dick | Bankhaus Lampe KG |
| Charles Pitman-King | Barclays |
| Scott Bardo | Berenberg |